Market Closed

NXTC
NextCure
$ 6.40
2.73%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

NextCure News

Latest NextCure Stock News & NXTC Headlines

NextCure Provides Business Update and Reports Third Quarter 2026 Financial Results
4 days ago | globenewswire.com
NextCure (NASDAQ:NXTC) Stock Price Up 7.7% – Time to Buy?
2 months ago | defenseworld.net
Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001
3 months ago | prnewswire.com
NextCure, Inc. (NASDAQ:NXTC) Sees Large Increase in Short Interest
4 months ago | defenseworld.net
Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders
4 months ago | globenewswire.com
Nextcure Transforms Into Avere as Investors Back Oral Psoriasis Therapy
4 months ago | benzinga.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of NextCure, Inc. (NASDAQ: NXTC)
4 months ago | gurufocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of NextCure, Inc. (NASDAQ: NXTC)
4 months ago | prnewswire.com
Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders
4 months ago | gurufocus.com
Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders
4 months ago | prnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

NXTC
NextCure
$ 6.40
2.73%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago